[Development of a conceptual model for interpretation of monitoring indicators of cancer screenings from the Italian National Prevention Plan].

Sviluppo di un modello concettuale di riferimento per l’interpretazione degli indicatori di monitoraggio degli screening oncologici nel Piano nazionale della prevenzione.

Journal

Epidemiologia e prevenzione
ISSN: 1120-9763
Titre abrégé: Epidemiol Prev
Pays: Italy
ID NLM: 8902507

Informations de publication

Date de publication:
Historique:
entrez: 30 10 2019
pubmed: 30 10 2019
medline: 24 4 2020
Statut: ppublish

Résumé

the Italian National Prevention Plan (PNP) posed the standard to be achieved by Italian Regions for the implementation of cervical, breast, and colorectal cancer screening: to invite all of the target populations and to increase the screening uptake up to 50%, 60%, and 50%, respectively, the standard defined by the Essential Levels of Care (LEA). Moreover, for cervical cancer screening, it requires the implementation of HPV-DNA test and, for breast cancer screening, the PNP demands for the definition of diagnostic and follow up pathways for high familial risk women. The PNP also set up a monitoring system to assess the impact of implemented policies. A conceptual model has been defined to facilitate interpretation of variation in outcome indicators. after a systematic review, the DPSEEA (Driving forces, Pressure, State, Exposure, Effect, Actions) was identified as the more appropriate framework to assess the results of preventive policies. Factors for each component of the model were identified and indicators that allow measuring the changing of each of these factors were defined. among the "driving forces", the trust in the health care system and the social capital were included. The presence of opportunistic screening, the competing private clinical activity, the commitment of General Practitioners and "medical" leaders, the attitude to cooperation and to patients' involvement, and the level of agreement between the positions of scientific societies and the recommendations implemented in organized screening programmes were included in the "pressures". In "state", the availability of technological and human resources, the level of management skills and of accessibility were identified. The "exposure" was defined as the coverage of active invitation of the target population and the uptake of screening tests. The "exposure" factors influence the "effect", described as the impact on anticipation of cancer diagnosis, on disease incidence (for cervical and colorectal cancer) and prognosis. The changing in screening programs performance modifies the impact of invitation coverage and test uptake ("exposure"). through the DPSEEA framework, we set up a logical conceptual model, which includes implementable actions and the mechanisms through which these actions should impact on the "exposure" (invitation coverage and screening uptake) and on the screening performance (quality).

Identifiants

pubmed: 31659883
doi: 10.19191/EP19.5-6.P354.105
doi:

Types de publication

Journal Article

Langues

ita

Sous-ensembles de citation

IM

Pagination

354-363

Auteurs

Marco Zappa (M)

Struttura complessa di epidemiologia clinica, Istituto per lo studio, la ricerca e la rete oncologica (ISPRO), Firenze.

Francesco Bevere (F)

Agenzia nazionale per i servizi sanitari regionali (Agenas), Roma.

Mario Braga (M)

Agenzia nazionale per i servizi sanitari regionali (Agenas), Roma.

Serena Broccoli (S)

Servizio di epidemiologia, Azienda unità sanitaria locale-IRCCS di Reggio Emilia, Reggio Emilia.

Mimma Cosentino (M)

Agenzia nazionale per i servizi sanitari regionali (Agenas), Roma.

Daniela Galeone (D)

Ministero della salute, Roma.

Antonio Federici (A)

Ministero della salute, Roma.

Mariagrazia Marvulli (M)

Agenzia nazionale per i servizi sanitari regionali (Agenas), Roma.

Stefania Vasselli (S)

Ministero della salute, Roma.

Francesco Venturelli (F)

Servizio di epidemiologia, Azienda unità sanitaria locale-IRCCS di Reggio Emilia, Reggio Emilia; venturelli.dr.francesco@gmail.com.
Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena.

Mariadonata Bellentani (M)

Ministero della salute, Roma.

Paolo Giorgi Rossi (P)

Servizio di epidemiologia, Azienda unità sanitaria locale-IRCCS di Reggio Emilia, Reggio Emilia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH